Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Study Questions Uniform Stool-Test Cutoff Across Age Groups

By LabMedica International staff writers
Posted on 19 Nov 2026

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U. More...

K. Early-onset colorectal cancer, defined as diagnosis before age 50, is also increasing globally, raising concerns about timely diagnosis in younger symptomatic patients. New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.

A University of Nottingham-led study evaluated fecal immunochemical testing (FIT) for colorectal cancer diagnosis in symptomatic patients under age 50. FIT is used by general practitioners to detect microscopic traces of blood in stool from patients with symptoms that may indicate colorectal cancer. Under the current practice described in the study, patients with FIT results of 10 or above are referred for urgent hospital investigation, including colonoscopy, while a negative result indicates a very low risk of cancer.

The research team reviewed all available studies of FIT use in symptomatic patients under 50 and compared the findings with those from patients over 50. The analysis included 12 studies involving more than 69,000 people under 50 who had symptoms and underwent FIT testing. Among younger patients tested with FIT, approximately 1 in 300, or 0.35%, were diagnosed with colorectal cancer, while the risk among patients over 50 was three to seven times higher.

The findings indicate that FIT performs well for detecting colorectal cancer in symptomatic patients, but suggest that the same threshold of 10 may not be equally appropriate across age groups. Because colorectal cancer is less common in younger adults, more patients under 50 would need to undergo invasive investigation to detect one cancer case compared with older adults.

The study, titled “Diagnostic performance of faecal immunochemical testing (FIT) for colorectal cancer in symptomatic patients under 50 years tested in primary care: a systematic review,” was published in Gut, and involved the University of Nottingham, the School of Medicine, the NIHR Nottingham Biomedical Research Centre, COLOREACH-UK, and Fight Colorectal Cancer.

“Early-onset colorectal cancer is rising worldwide, and this is exactly the kind of question our Global Research Collaborative was built to answer. By pooling evidence across countries, this team has shown that one FIT threshold may not work equally well for every age group. Fight CRC is proud to have brought this group together, and we look forward to the next steps toward better, more tailored diagnosis for people under 50,” said Anjee Davis, MPPA, chief executive officer of Fight Colorectal Cancer.

Related Links
University of Nottingham


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.